NasdaqGS - Nasdaq Real Time Price USD

Zynex, Inc. (ZYXI)

11.21

+0.27

(+2.47%)

At close: April 26 at 4:00 PM EDT

10.94

-0.27

(-2.41%)

After hours: April 26 at 6:43 PM EDT

Investing in Zynex (NASDAQ:ZYXI) five years ago would have delivered you a 82% gain

Zynex, Inc. ( NASDAQ:ZYXI ) shareholders might be concerned after seeing the share price drop 11% in the last month...

Simply Wall St. 20 hours ago

ZYXI
+2.47%
Zynex Sets First Quarter 2024 Earnings Call

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, April 30, 2024 at 4:15 PM Eastern Time to discuss its financial results for the first quarter ended March 31, 2024. Financial results will be issued in a press release prior to the call.

PR Newswire 8 days ago

ZYXI
+2.47%
3 Industrial Stocks Short Sellers Are Hammering: Cracks in the Foundation?

There are some industrial stocks that short sellers are targeting heavily in April this year. Short sellers often target stocks they perceive to be overvalued or companies facing significant challenges or headwinds. By short selling, they stand to profit if the stock price drops as they can buy back the borrowed shares at a lower cost than what they sold them for initially. Thus, a high short interest can be both a warning sign and an opportunity, depending if you own or want to sell shares. The

InvestorPlace 24 days ago

ZYXI
+2.47%
PCTTW
Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it is a recipient of the prestigious 2024 Top Workplaces USA award, featured in USA TODAY. This achievement underscores the organization's dedication to fostering a people-first workplace culture and prioritizing the employee experience.

PR Newswire 24 days ago

ZYXI
+2.47%
With 51% ownership, Zynex, Inc. (NASDAQ:ZYXI) insiders have a lot riding on the company's future

Key Insights Zynex's significant insider ownership suggests inherent interests in company's expansion The top 2...

Simply Wall St. 27 days ago

ZYXI
+2.47%
Zynex Full Year 2023 Earnings: Misses Expectations

Zynex ( NASDAQ:ZYXI ) Full Year 2023 Results Key Financial Results Revenue: US$184.3m (up 17% from FY 2022). Net...

Simply Wall St. last month

ZYXI
+2.47%
Zynex, Inc. (NASDAQ:ZYXI) Q4 2023 Earnings Call Transcript

Zynex, Inc. (NASDAQ:ZYXI) Q4 2023 Earnings Call Transcript February 29, 2024 Zynex, Inc. beats earnings expectations. Reported EPS is $0.21, expectations were $0.17. ZYXI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen. And welcome to […]

Insider Monkey last month

ZYXI
+2.47%
Zynex Price Target Raised by RBC Capital, HC Wainwright Analysts

By Exec Edge Editorial Staff RBC Capital analyst Shagun Singh maintained Zynex, Inc. (Nasdaq:ZYXI) with an outperform rating and raised its price target from $13 to $15. Meanwhile, HC Wainwright & Co. analyst Yi Chen maintained a buy rating and raised its price target from $20 to $21. The Englewood, CO. company, founded in 1996, […]

Exec Edge last month

ZYXI
+2.47%
Zynex Inc. (ZYXI) Q4 Earnings and Revenues Miss Estimates

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of -76.47% and 12.44%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

ZYXI
+2.47%
Zynex Inc (ZYXI) Reports 17% Revenue Growth in FY 2023, Announces New $20 Million Stock ...

Despite Revenue Uplift, Net Income and Adjusted EBITDA Experience Downturn

GuruFocus.com last month

ZYXI
+2.47%
Zynex Reports Fourth Quarter and Full Year 2023 Financial Results

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2023 and its Board of Directors has approved an additional program to repurchase up to $20.0 million of the Company's common stock.

PR Newswire last month

ZYXI
+2.47%
Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, February 29, 2024 at 4:15 PM Eastern Time to discuss its financial results for the fourth quarter and full year ended December 31, 2023. Financial results will be issued in a press release prior to the call.

PR Newswire 2 months ago

ZYXI
+2.47%
Zynex Introduces New Products

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, introduced two new therapy products: the Zynex Pro Hybrid LSO and the Zynex DynaComp Cold Compression.

PR Newswire 2 months ago

ZYXI
+2.47%
Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023

SRFC further demonstrated its presence by representing organizations on IPOs, public and private offerings, and other market activity in 2023 Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023 SRFC's Most Notable Transactions throughout 2023 NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Today, Sichenzia Ross Ference Carmel LLP (“SRFC”), a full-service law firm internationally recognized for its securities and litigation practices, ann

GlobeNewswire 2 months ago

MWG

EJH

ZYXI
+2.47%
Zynex Receives FDA Clearance for its Next Generation NMES Device

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has received clearance from the U.S. Food and Drug Administration ("FDA") for the next generation M-Wave Neuromuscular Electrical Stimulation ("NMES") device.

PR Newswire 2 months ago

ZYXI
+2.47%
Zynex Recognized in Top 25 Medical Device Companies for 2024

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced The Healthcare Technology Report recognized Zynex as 9th amongst the Top 25 Medical Device Companies for 2024.

PR Newswire 2 months ago

ZYXI
+2.47%
3 Unloved Growth Stocks Poised for a Major Turnaround

The stock market recovery over the past couple of years has been anything but evenly-distributed. A handful of high-flying tech stocks dubbed the “Magnificent Seven” have largely powered the rebound, overshadowing many other quality businesses. As a growth investor, it can be easy to feel like you’ve missed the boat. However, that couldn’t be further from the truth. While the market’s spotlight has centered on big tech, many compelling growth stocks across various sectors remain overlooked. Thei

InvestorPlace 2 months ago

ZYXI
+2.47%
GAMB
Zynex to Participate at the Needham Annual Growth Conference

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will participate virtually in the upcoming Needham Annual Growth Conference, which is being held January 16th-19th, 2024.

PR Newswire 3 months ago

ZYXI
+2.47%
Is Zynex, Inc.'s (NASDAQ:ZYXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Most readers would already be aware that Zynex's (NASDAQ:ZYXI) stock increased significantly by 35% over the past three...

Simply Wall St. 3 months ago

ZYXI
+2.47%
Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum

The post Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum appeared first on CorpGov.

CorpGov.com 4 months ago

ZYXI
+2.47%

Performance Overview

Return	ZYXI	S&P 500
YTD	+2.94%	+6.92%
1-Year	-2.52%	+25.26%
3-Year	-22.94%	+22.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Zynex, Inc. (ZYXI)

Investing in Zynex (NASDAQ:ZYXI) five years ago would have delivered you a 82% gain

Zynex Sets First Quarter 2024 Earnings Call

3 Industrial Stocks Short Sellers Are Hammering: Cracks in the Foundation?

Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award

With 51% ownership, Zynex, Inc. (NASDAQ:ZYXI) insiders have a lot riding on the company's future

Zynex Full Year 2023 Earnings: Misses Expectations

Zynex, Inc. (NASDAQ:ZYXI) Q4 2023 Earnings Call Transcript

Zynex Price Target Raised by RBC Capital, HC Wainwright Analysts

Zynex Inc. (ZYXI) Q4 Earnings and Revenues Miss Estimates

Zynex Inc (ZYXI) Reports 17% Revenue Growth in FY 2023, Announces New $20 Million Stock ...

Zynex Reports Fourth Quarter and Full Year 2023 Financial Results

Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call

Zynex Introduces New Products

Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023

Zynex Receives FDA Clearance for its Next Generation NMES Device

Zynex Recognized in Top 25 Medical Device Companies for 2024

3 Unloved Growth Stocks Poised for a Major Turnaround

Zynex to Participate at the Needham Annual Growth Conference

Is Zynex, Inc.'s (NASDAQ:ZYXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum

Performance Overview